Abiogen Pharma

Abiogen Pharma develops, manufactures, and markets pharmaceutical drugs, medical devices, food supplements, and specialized medical foods. The company focuses its research and product portfolio across key therapeutic areas: bone metabolism, hypovitaminosis D, pain management, viscosupplementation, dermatology, respiratory conditions, and diabetology. Its technical approach emphasizes continuous scientific research and innovation.

While the corporate entity Abiogen Pharma was established in 1997, its roots extend over a century through a family business history. It represents the culmination of five generations dedicated to pharmaceutical development, driven by an enduring passion for scientific inquiry and a commitment to industry evolution. This long-standing lineage underpins its deep scientific and technological knowledge.

Abiogen Pharma serves the medical community and patients across its specialized therapeutic fields, both domestically and internationally. The company aims to be a trusted reference for healthcare professionals by providing effective and innovative solutions. Its long-term vision centers on leveraging scientific heritage and international presence to advance healthcare and improve patient well-being.